Theranos plans massive Dx expansion in Arizona; Duke University spinoff raises cash to fuel quicker POC tests;

> California diagnostics company Theranos plans to expand to Scottsdale, AZ, and will hire 500 new people. Story

> The Broad Institute of MIT and Harvard received a $650 million donation for psychiatric research, money that will analyze genes responsible for diseases such as schizophrenia and bipolar disorder. Story | More from FierceBiotech

> Illumina ($ILMN) and Berry Genomics have agreed to develop a next-generation sequencing system that uses tech from both companies for review and approval in China. Item

> Duke University spinoff SenGenix raised $2.5 million toward development of a new way to enable quicker point-of-care diagnostics in the doctor's office. Story

> The New York City Economic Development Corp. is seeking VC partners to back diagnostics and med tech startups. Story

> Vivione Biosciences won certification for its new rapid E. coli diagnostic tests, which are designed to produce results within 7 hours or less. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.